Skip to main content

ProAir HFA FDA Approval History

FDA Approved: Yes (First approved October 29, 2004)
Brand name: ProAir HFA
Generic name: albuterol sulfate
Dosage form: Inhalation Aerosol
Company: Teva Pharmaceutical Industries Ltd.
Treatment for: Asthma

ProAir HFA (albuterol sulfate) inhalation aerosol is a beta2-adrenergic agonist indicated for treatment or prevention of bronchospasm.

Development timeline for ProAir HFA

Sep 24, 2008Approval Teva's ProAir HFA, the Market Leading Albuterol Inhaler, Receives New Pediatric Indication

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.